Scilex Holding Co
SCLX14.480USD
+1.070+7.98%
交易中 （美東）報價延遲15分鐘
79.54M總市值
虧損本益比TTM
關於 Scilex Holding Co 公司
Scilex Holding Company 專注於收購、開發和商業化用於治療急性和慢性疼痛的非阿片類止痛藥。該公司的商業產品 ZTlido（利多卡因外用系統）1.8% 是一種處方利多卡因外用產品，用於緩解帶狀皰疹後神經痛相關的疼痛，帶狀皰疹後神經痛是一種帶狀皰疹後神經痛。該公司還專注於商業化口服溶液 Gloperba（秋水仙鹼 USP），這是一種預防成人痛風發作的藥物。其第二個商業產品 ELYXYB 是一種潛在的一線治療藥物，是一種即用型口服溶液，用於成人偏頭痛的急性治療，無論有無先兆。其候選產品包括 SP-102（SEMDEXA）、SP-103 和 SP-104。SP-102 是一種粘稠凝膠製劑，是一種皮質類固醇，用於硬膜外注射治療腰骶神經根痛或坐骨神經痛。其 SP-103 是 ZTlido 的三倍強度配方，用於治療慢性頸部疼痛。
公司簡介
公司代碼SCLX
公司名稱Scilex Holding Co
上市日期Jan 11, 2021
CEOMr. Jaisim Shah
員工數量115
證券類型Ordinary Share
年結日Jan 11
公司地址960 San Antonio Road
城市PALO ALTO
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編94303
電話16505164310
網址https://www.scilexholding.com/
公司代碼SCLX
上市日期Jan 11, 2021
CEOMr. Jaisim Shah
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Henry H. Ji, Ph.D.
Dr. Henry H. Ji, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
19.45K
+3398.56%
Mr. Jaisim Shah
Mr. Jaisim Shah
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
8.43K
+3399.17%
Dr. Jay Chun, M.D., Ph.D.
Dr. Jay Chun, M.D., Ph.D.
Independent Director
Independent Director
3.21K
+3393.48%
Dr. Yue Alexander Wu, Ph.D.
Dr. Yue Alexander Wu, Ph.D.
Independent Director
Independent Director
714.00
+3470.00%
Mr. Dorman Followwill
Mr. Dorman Followwill
Independent Director
Independent Director
65.00
+3150.00%
Dr. Annu Navani, M.D.
Dr. Annu Navani, M.D.
Independent Director
Independent Director
--
--
Mr. Stephen Ma
Mr. Stephen Ma
Chief Financial Officer, Senior Vice President, Corporate Secretary
Chief Financial Officer, Senior Vice President, Corporate Secretary
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Henry H. Ji, Ph.D.
Dr. Henry H. Ji, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
19.45K
+3398.56%
Mr. Jaisim Shah
Mr. Jaisim Shah
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
8.43K
+3399.17%
Dr. Jay Chun, M.D., Ph.D.
Dr. Jay Chun, M.D., Ph.D.
Independent Director
Independent Director
3.21K
+3393.48%
Dr. Yue Alexander Wu, Ph.D.
Dr. Yue Alexander Wu, Ph.D.
Independent Director
Independent Director
714.00
+3470.00%
Mr. Dorman Followwill
Mr. Dorman Followwill
Independent Director
Independent Director
65.00
+3150.00%
Dr. Annu Navani, M.D.
Dr. Annu Navani, M.D.
Independent Director
Independent Director
--
--
收入明細
FY2024
FY2023
FY2022
FY2021
FY2020
暫無數據
地區USD
名稱
營收
佔比
United States
56.59M
0.00%
業務
地區
暫無數據
股東統計
更新時間: 7月2日 週三
更新時間: 7月2日 週三
持股股東
股東類型
持股股東
持股股東
佔比
SCLX Stock Acquisition JV LLC
20.96%
Armistice Capital LLC
5.67%
State Street Global Advisors (US)
3.12%
The Vanguard Group, Inc.
2.42%
BlackRock Institutional Trust Company, N.A.
2.32%
Other
65.51%
持股股東
持股股東
佔比
SCLX Stock Acquisition JV LLC
20.96%
Armistice Capital LLC
5.67%
State Street Global Advisors (US)
3.12%
The Vanguard Group, Inc.
2.42%
BlackRock Institutional Trust Company, N.A.
2.32%
Other
65.51%
股東類型
持股股東
佔比
Corporation
21.11%
Hedge Fund
6.20%
Investment Advisor
5.95%
Investment Advisor/Hedge Fund
5.29%
Individual Investor
0.47%
Venture Capital
0.43%
Research Firm
0.37%
Sovereign Wealth Fund
0.20%
Pension Fund
0.09%
Other
59.90%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
242
2.85M
41.39%
-727.96K
2025Q1
252
1.46M
45.15%
-3.55M
2024Q4
251
112.59M
54.83%
-47.55M
2024Q3
250
97.43M
52.53%
-74.03M
2024Q2
251
103.17M
56.73%
-57.85M
2024Q1
249
91.86M
57.21%
-68.00M
2023Q4
233
89.70M
66.12%
-73.38M
2023Q3
225
92.65M
59.63%
-2.57M
2023Q2
215
84.74M
56.99%
-3.00M
2023Q1
187
79.37M
78.26%
-5.74M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
SCLX Stock Acquisition JV LLC
1.46M
20.98%
+1.42M
+3399.97%
May 01, 2025
Armistice Capital LLC
394.06K
5.67%
-116.72K
-22.85%
Mar 31, 2025
State Street Global Advisors (US)
216.87K
3.12%
+2.40K
+1.12%
Mar 31, 2025
The Vanguard Group, Inc.
168.51K
2.42%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
161.07K
2.32%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
46.00K
0.66%
+10.32K
+28.93%
Mar 31, 2025
RA Capital Management, LP
29.61K
0.43%
--
--
Mar 31, 2025
Northern Trust Investments, Inc.
22.63K
0.33%
+1.74K
+8.35%
Mar 31, 2025
BlackRock Financial Management, Inc.
21.34K
0.31%
--
--
Mar 31, 2025
UBS Financial Services, Inc.
20.53K
0.3%
+18.12K
+751.56%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Virtus LifeSci Biotech Clinical Trials ETF
0.03%
Direxion Daily S&P Biotech Bull 3X Shares
0.02%
Invesco NASDAQ Future Gen 200 ETF
0.01%
iShares Micro-Cap ETF
0.01%
Proshares Ultra Russell 2000
0%
Strive Small-Cap ETF
0%
Janus Henderson Small Cap Growth Alpha ETF
0%
DFA Dimensional US Core Equity Market ETF
0%
SPDR Portfolio MSCI Global Stock Market ETF
0%
Vanguard Total World Stock Index Fund
0%
查看更多
Virtus LifeSci Biotech Clinical Trials ETF
佔比0.03%
Direxion Daily S&P Biotech Bull 3X Shares
佔比0.02%
Invesco NASDAQ Future Gen 200 ETF
佔比0.01%
iShares Micro-Cap ETF
佔比0.01%
Proshares Ultra Russell 2000
佔比0%
Strive Small-Cap ETF
佔比0%
Janus Henderson Small Cap Growth Alpha ETF
佔比0%
DFA Dimensional US Core Equity Market ETF
佔比0%
SPDR Portfolio MSCI Global Stock Market ETF
佔比0%
Vanguard Total World Stock Index Fund
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
